M. KARABULUT Et Al. , "SERUM INTERLEUKIN-32 (IL-32) LEVELS MAY HAVE DIAGNOSTIC AND PROGNOSTIC ROLES IN PATIENTS WITH PANCREATIC ADENOCARCINOMA," ACTA MEDICA MEDITERRANEA , vol.33, no.4, pp.613-619, 2017
KARABULUT, M. Et Al. 2017. SERUM INTERLEUKIN-32 (IL-32) LEVELS MAY HAVE DIAGNOSTIC AND PROGNOSTIC ROLES IN PATIENTS WITH PANCREATIC ADENOCARCINOMA. ACTA MEDICA MEDITERRANEA , vol.33, no.4 , 613-619.
KARABULUT, M., Afsar, C. U., KARABULUT, S., PEKER, K. D., GEMICI, E., Dagoglu, N., ... KARAMAN, Ş.(2017). SERUM INTERLEUKIN-32 (IL-32) LEVELS MAY HAVE DIAGNOSTIC AND PROGNOSTIC ROLES IN PATIENTS WITH PANCREATIC ADENOCARCINOMA. ACTA MEDICA MEDITERRANEA , vol.33, no.4, 613-619.
KARABULUT, ÇİĞDEM Et Al. "SERUM INTERLEUKIN-32 (IL-32) LEVELS MAY HAVE DIAGNOSTIC AND PROGNOSTIC ROLES IN PATIENTS WITH PANCREATIC ADENOCARCINOMA," ACTA MEDICA MEDITERRANEA , vol.33, no.4, 613-619, 2017
KARABULUT, ÇİĞDEM U. Et Al. "SERUM INTERLEUKIN-32 (IL-32) LEVELS MAY HAVE DIAGNOSTIC AND PROGNOSTIC ROLES IN PATIENTS WITH PANCREATIC ADENOCARCINOMA." ACTA MEDICA MEDITERRANEA , vol.33, no.4, pp.613-619, 2017
KARABULUT, M. Et Al. (2017) . "SERUM INTERLEUKIN-32 (IL-32) LEVELS MAY HAVE DIAGNOSTIC AND PROGNOSTIC ROLES IN PATIENTS WITH PANCREATIC ADENOCARCINOMA." ACTA MEDICA MEDITERRANEA , vol.33, no.4, pp.613-619.
@article{article, author={ÇİĞDEM USUL AFŞAR Et Al. }, title={SERUM INTERLEUKIN-32 (IL-32) LEVELS MAY HAVE DIAGNOSTIC AND PROGNOSTIC ROLES IN PATIENTS WITH PANCREATIC ADENOCARCINOMA}, journal={ACTA MEDICA MEDITERRANEA}, year=2017, pages={613-619} }